Mariana Murea to Kidney Failure, Chronic
This is a "connection" page, showing publications Mariana Murea has written about Kidney Failure, Chronic.
Connection Strength
5.163
-
Murea M, Moossavi S, Fletcher AJ, Jones DN, Sheikh HI, Russell G, Kalantar-Zadeh K. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial. BMJ Open. 2021 05 24; 11(5):e047596.
Score: 0.543
-
Bowline IG, Russell GB, Bagwell B, Crossley B, Fletcher AJ, Murea M. Temporal trends in fluid management with incremental hemodialysis?. Clin Nephrol. 2019 Oct; 92(4):165-173.
Score: 0.484
-
Murea M, Geary RL, Davis RP, Moossavi S. Vascular access for hemodialysis: A perpetual challenge. Semin Dial. 2019 11; 32(6):527-534.
Score: 0.474
-
Murea M, Ma L, Freedman BI. APOL1 and Mortality in Patients on Dialysis. Cardiorenal Med. 2019; 9(4):261-264.
Score: 0.474
-
Murea M, Tucker BM. The physiology of uric acid and the impact of end-stage kidney disease and dialysis. Semin Dial. 2019 01; 32(1):47-57.
Score: 0.445
-
Murea M, Brown WM, Divers J, Moossavi S, Robinson TW, Bagwell B, Burkart JM, Freedman BI. Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study. Am J Nephrol. 2017; 46(4):268-275.
Score: 0.421
-
Murea M, Burkart J. Finding the right hemodialysis vascular access in the elderly: a patient-centered approach. J Vasc Access. 2016 Sep 21; 17(5):386-391.
Score: 0.389
-
Murea M, James KM, Russell GB, Byrum GV, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol. 2014 Apr; 9(4):764-70.
Score: 0.330
-
Murea M. Advanced kidney failure and hyperuricemia. Adv Chronic Kidney Dis. 2012 Nov; 19(6):419-24.
Score: 0.300
-
Freedman BI, Murea M. Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep. 2012 Feb; 14(1):21-8.
Score: 0.285
-
Murea M, Lu L, Ma L, Hicks PJ, Divers J, McDonough CW, Langefeld CD, Bowden DW, Freedman BI. Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. Am J Nephrol. 2011; 33(6):502-9.
Score: 0.270
-
Freedman BI, Murea M. Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes. Semin Dial. 2010 May-Jun; 23(3):244-7.
Score: 0.252
-
Murea M, Freedman BI. Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens. 2010 May; 19(3):235-41.
Score: 0.252
-
Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant. 2014 Mar; 29(3):587-94.
Score: 0.080
-
Freedman BI, Langefeld CD, Turner J, Núñez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012 Oct; 82(7):805-11.
Score: 0.073
-
Deshpande P, Chen J, Gofran A, Murea M, Golestaneh L. Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED). Nephrol Dial Transplant. 2010 Aug; 25(8):2632-6.
Score: 0.062
-
Freedman BI, Spainhour M, Hicks PJ, Turner J, Robertson J, Langefeld CD, Murea M, Divers J. Nephropathy Progression in African Americans With a Family History of ESKD: Implications for Clinical Trials in APOL1-Associated Nephropathy. Am J Kidney Dis. 2019 08; 74(2):284-286.
Score: 0.029